1. Procedure for inclusion of medicinal products in PDL, including and formation of price
2. Procedure for exclusion of medicinal product from PDL and including deletion of price
3. Procedure for changing a medicinal product included in the PDL (change of name, change of Marketing Authorisation Holder, change of manufacturer, change of evidence, change of price under Article 261a, paragraph 1 of LMPHM, change in other registered
4. Procedure for the formation of the ceiling price of a medicinal product subject to medical prescription
5. Procedure for changing the formed ceiling price of a medicinal product subject to medical prescription
6. Procedure for deletion of the ceiling price of a medicinal product subject to medical prescription
7. Procedure for changing circumstances in the decision as to ceiling price (change of name, change of Marketing Authorisation Holder; change of manufacturer; change in other registered circumstances)
8. Procedure for registering price of a medicinal product, dispensed without medical prescription
9. Procedure for changing the registered price of a medicinal product, dispensed without medical prescription
10. Procedure for deletion of registered price of a medicinal product dispensed without medical prescription
11. Procedure for the change in circumstances in the decision for the registered price of a medicinal product dispensed without medical prescription (change of name, change of the Marketing Authorisation Holder; change of manufacturer, change in other re registered circumstances)
12. Procedure for inclusion of a medicinal product in the PDL authorised for parallel import
13. Procedure for implementation of the formed ceiling price of a medicinal product authorised for parallel import
14. Procedure for implementation of the registered maximum sale price of a medicinal product authorized for parallel import
15. Procedure for exclusion of a medicinal product from the PDL and inscription of the price under Article 261a, paragraph1 of LMPHM in the register under Section 22 of the Ordinance
16. Maintaining the reimbursement status of a medicinal product included in the Positive Drug List
17. Carrying out a Health Technology Assessment of a medicinal product included in the PDL
18. Declaration for certification of circumstances pursuant to Art. 43, para. 1 and para. 2
19. Application for change of approved price in accordance with Art. 43, para. 3 and para. 4